Investigations

Every investigation we've published, newest first — each one built on primary documents and classified under our evidence standard.

Topics Corporations·Government·Institutions·Public Figures·Fraud & Deception·Media
Fraud & Deception — 6 August 2024 — 7 min read

National Auto Protection Corp.: The Vehicle Warranty Telemarketer the FTC Banned From the Industry After Millions of Illegal Robocalls

The FTC imposed a permanent ban on National Auto Protection Corp. and its principals from the vehicle protection services industry following findings that the company made millions of illegal robocalls using spoofed caller IDs and deceptive scripts claiming to be from consumers' car dealers or manufacturers.

Read the full report
Institutions — 5 August 2024 — 6 min read

American Addiction Centers: The For-Profit Rehab Chain the DOJ Says Billed for Treatment It Did Not Deliver

Federal investigators found American Addiction Centers submitted claims to Medicare and Medicaid for substance use disorder treatment sessions that were not provided as billed — including group therapy attributed to licensed counselors who were not present — generating False Claims Act liability for the national rehab chain.

Read the full report
Corporations — 29 July 2024 — 7 min read

Suburban Propane: The EPA Found the Propane Distributor Releasing Methane at Levels Exceeding Clean Air Act Permit Limits

The EPA cited Suburban Propane Partners for methane and volatile organic compound emissions at propane storage and distribution facilities that exceeded Clean Air Act permit limits, finding the company had failed to implement required leak detection and repair programs and emissions controls at affected sites.

Read the full report
Corporations — 23 July 2024 — 7 min read

Surescripts: The FTC Monopolization Lawsuit Against the E-Prescribing Network That Controls 95 Percent of U.S. Electronic Prescriptions

The FTC sued Surescripts for illegally maintaining its monopoly over electronic prescription routing and eligibility networks by imposing exclusivity requirements and loyalty penalties that prevented pharmacies and pharmacy benefit managers from switching to or supporting competing e-prescribing networks.

Read the full report